ADVIL LIQUI-GELS (ibuprofen) by GSK is cyclooxygenase inhibitors [moa]. First approved in 1995.
Drug data last refreshed 9h ago · AI intelligence enriched 12h ago
ADVIL LIQUI-GELS is an oral ibuprofen capsule, a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes to reduce pain, fever, and inflammation. It is a widely used over-the-counter analgesic indicated for minor aches and pains across multiple therapeutic areas.
As an OTC product approaching loss of exclusivity in a highly commoditized market, commercial teams face sustained competitive pressure with limited growth runway and potential headcount optimization.
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension
Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain
Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain
Postoperative Analgesic Effects of Ibuprofen Versus Ketorolac in Patients Undergoing in Orthopedic Surgery
Ibuprofen Plus Acetaminophen for Enhanced Pain Reduction
Worked on ADVIL LIQUI-GELS at GSK? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on ADVIL LIQUI-GELS offers limited career growth due to the product's mature, generic-threatened lifecycle and absence of linked job openings. Roles are primarily in defensive commercial management, trade marketing, and cost optimization rather than innovation or expansion.